Animal health company Zoetis is expanding its manufacturing and development facility in Tullamore in Co Offaly, which will potentially create 80 to 100 new jobs over the next three years.
The company said that some roles will start to phase in later this year.
Zoetis said the expansion will significantly increase its capacity for producing veterinary monoclonal antibodies (mAbs) over time.
These therapeutic biopharmaceuticals are the latest breakthroughs in animal medicine from Zoetis' pipeline of products.
Zoetis currently employs about 90 highly skilled scientists and technicians on the Tullamore site, which became part of the Zoetis network when it acquired from Nexvet Biopharma in 2017.
The Tullamore expansion builds on the company's current operations in Ireland, which includes commercial offices and manufacturing sites, employing more than 450 people.
It has offices in Cherrywood in Dublin, an active pharmaceutical ingredient manufacturing site in Rathdrum, Co Wicklow and a facility in Tallaght in Dublin.
Conor O'Dea, Site Lead at Zoetis, said with the high concentration of biologic manufacturing sites in the area and the skilled Irish workforce, it has built a strong team with extensive experience in all aspects of biopharmaceuticals manufacture, process development, quality, engineering and supply chain.
"We look forward to developing it further with this investment. The expansion will offer current and future employees tremendous experience and career opportunities," he added.
Minister of State for Trade Promotion, Digital and Company Regulation, Robert Troy said news of the expansion was a very welcome announcement for the local and wider Midland's region.
He said it demonstrates that the Midlands has the skills, talent, people, and connectivity that will enable companies like Zoetis to embed and grow its operations here.
IDA Ireland CEO Martin Shanahan said the new biotech facility by the world’s leading veterinary medicines company adds another globally established name to the significant and growing cluster of biopharma companies operating in Ireland.
"This expansion demonstrates Zoetis’ confidence in the highly skilled and talented workforce available in the Midlands and exemplifies IDA Ireland’s continued commitment to winning jobs and investment in regional locations," he added.